University of Tennessee Cancer Institute

The University of Tennessee Cancer Institute is a unique partnership between the UT Health Science Center and Boston Baskin Cancer Group. This singular association combines the research and teaching capabilities of a leading institution of higher learning with the patient care of the Mid-South's largest cancer physicians group.The immediate goal of this collaboration is to provide the best possible care for hematology and oncology patients in this region of the country, through two cancer centers and eight additional clinical sites, while the long-term objective is to help eradicate cancer through innovative research. The collaboration includes other major healthcare and research institutions in and around Memphis.

Contact Details: 1331 Union Avenue Suite 800 Memphis Tennessee 38104 United States of America Tel: 901-725-1785 Fax: Email: info@utcancer.com WWW: www.utcancerinstitute.com/

Loading...

Recent Publications by University of Tennessee Cancer Institute:
Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions. Extensive-stage small-cell lung cancer (ES-SCLC) is one of the most lethal...	17th December, 2008	University of Tennessee Cancer Institute, Memphis, TN 38104, USA.	Clin Lung Cancer. 2008 Sep;9(5):262-70.
Neoadjuvant chemotherapy in stage III NSCLC. Non-small cell lung cancer (NSCLC) continues to be the leading cause of...	18th June, 2008	University of Tennessee Cancer Institute, Memphis, Tennessee, USA.	J Natl Compr Canc Netw. 2008 Mar;6(3):285-93.
Characterization of gene expression profiles of 3 different human oral squamous cell carcinoma cell lines with different invasion and metastatic capacities. PURPOSE: The gene expression of 3 oral squamous cell carcinoma (OSCC)...	6th May, 2008	Department of Oral and Maxillofacial Surgery, University of Tennessee	J Oral Maxillofac Surg. 2008 May;66(5):918-27. DOI Direct Link
Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. Type I interferons (IFNs) regulate diverse cellular functions by...	5th March, 2008	Department of Pathology and Laboratory Medicine, University of Tennessee	J Cell Biochem. 2007 Dec 1;102(5):1087-94. DOI Direct Link
Surgical management of the neck in oral cancer. Non-small cell lung cancer (NSCLC) continues to be the leading cause of...	20th December, 2007	Department of Oral and Maxillofacial Surgery, University of Tennessee	Oral Maxillofac Surg Clin North Am. 2006 Nov;18(4):533-46. DOI Direct Link
→View more University of Tennessee Cancer Institute research publications.

Press Releases on University of Tennessee Cancer Institute:
NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment	20th November, 2009	National Comprehensive Cancer Network	NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN Clinical Practice Guidelines in Oncology(TM)
Annual Screening Mammography Continues to be Recommended in Updated NCCN Guidelines for Breast Cancer Screening and Diagnosis	16th November, 2009	National Comprehensive Cancer Network	FORT WASHINGTON, Pa., Nov. 16 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines in Oncology(TM) for Breast Cancer
NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies	10th November, 2009	National Comprehensive Cancer Network	NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the
NCCN Posts Comparative Effectiveness White Paper for Public Comment	9th November, 2009	National Comprehensive Cancer Network	The National Comprehensive Cancer Network (NCCN) has posted a draft white paper for public comment that details a draft paradigm for near-term comparative effectiveness clinical evaluations based upon
NCCN Guidelines for Kidney Cancer Updated to Include Pazopanib for Advanced Disease; Free Webinar Discusses Updates	3rd November, 2009	National Comprehensive Cancer Network	The NCCN Guidelines for Kidney Cancer have been updated to incorporate the recently approved therapy pazopanib as a treatment option for patients with advanced renal cell carcinoma. In conjunction

BioNews Results for University of Tennessee Cancer Institute:
Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Wome	Journal of Clinical Oncology:  Nov 11 2009 8:38PM Matching: university tennessee cancer institute

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 330 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: nccn comparative effectiveness | UT Cancer Institute | university tn cancer institute | university tn cancer institute | .

Search for more companies in Memphis

Search for more companies in Tennessee

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for University of Tennessee Cancer Institute